Active — Not RecruitingNot Applicable

Developing Microbials to Fight Extended-spectrum Beta-lactamase (ESBL)-Producing Escherichia Coli

Switzerland39 participantsStarted 2019-06-13

Plain-language summary

This study is to identify and isolate well-defined microbials (non-ESBL E. coli) in an observational setting exploring natural gastrointestinal decolonization of humans colonized with ESBL E. coli.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * travelling to Southeast Asia (India, Bhutan, Nepal, Bangladesh, Myanmar, Thailand, Laos, Cambodia, Vietnam) for a maximum of 4 weeks. Exclusion Criteria: * other travelling destinations than mentioned above * antibiotic use at the first sampling time * Participants who are not colonized will serve as a control group for microbiome comparison

What they're measuring

proportion of patients being "naturally" decolonized from ESBL E. coli

Timeframe: 18 months

Trial details

NCT IDNCT04764500

SponsorUniversity Hospital, Basel, Switzerland

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2020-02-09

View on ClinicalTrials.gov More Extended Spectrum Beta Lactamases (ESBL) E. Coli trials